{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:34:04Z","timestamp":1772174044709,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/02147-0"],"award-info":[{"award-number":["2017\/02147-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007762","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Translacional em Medicina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007762","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Translacional em Medicina","doi-asserted-by":"publisher","award":["465458\/2014-9"],"award-info":[{"award-number":["465458\/2014-9"]}],"id":[{"id":"10.13039\/501100007762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jchromb.2019.121809","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T11:19:59Z","timestamp":1570187999000},"page":"121809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Determination of anandamide in cerebrospinal fluid samples by disposable pipette extraction and ultra-high performance liquid chromatography tandem mass spectrometry"],"prefix":"10.1016","volume":"1130-1131","author":[{"given":"Igor Gustavo de Carvalho","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eug\u00eania Costa","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2019.121809_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpba.2015.03.017","article-title":"Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC\u2013MS\/MS: application in tumor-bearing mice","volume":"111","author":"Gong","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2019.121809_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.02.008","article-title":"Autoimmunity Reviews Cannabinoids and autoimmune diseases: a systematic review","author":"Katchan","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jchromb.2019.121809_b0015","volume":"258","author":"Devane","year":"1992","journal-title":"Only By"},{"key":"10.1016\/j.jchromb.2019.121809_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plefa.2018.11.016","article-title":"WITHDRAWN: the endocannabinoid system: overview of an emerging multi-faceted therapeutic target","volume":"140","author":"Chanda","year":"2018","journal-title":"Prostagland. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.jchromb.2019.121809_b0025","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/j.bmcl.2010.08.048","article-title":"Fatty acid amide signaling molecules","volume":"20","author":"Ezzili","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jchromb.2019.121809_b0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jchromb.2019.121809_b0035","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jchromb.2019.121809_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jchromb.2019.121809_b0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/mds.23014","article-title":"Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson\u2019s disease patients","volume":"25","author":"Pisani","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jchromb.2019.121809_b0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jchromb.2019.121809_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plefa.2017.04.005","article-title":"Plasma levels of the endocannabinoid anandamide, related N-acylethanolamines and linoleic acid-derived oxylipins in patients with migraine","volume":"120","author":"Gouveia-Figueira","year":"2017","journal-title":"Prostagland. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.jchromb.2019.121809_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.aca.2017.07.024","article-title":"Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry","volume":"984","author":"Wang","year":"2017","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jchromb.2019.121809_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.chroma.2017.06.029","article-title":"Investigation of changes in endocannabinoids and N-acylethanolamides in biofluids, and their correlations with female infertility","volume":"1509","author":"Ding","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2019.121809_b0070","first-page":"1","article-title":"Simultaneous HPLC-APCI-MS\/MS quantification of endogenous cannabinoids and glucocorticoids in hair","author":"Mwanza","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1028"},{"key":"10.1016\/j.jchromb.2019.121809_b0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00216-015-9150-z","article-title":"Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: Variations in metabolic syndrome","volume":"408","author":"Mutemberezi","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0080","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/rcm.7277","article-title":"A robust capillary liquid chromatography\/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids","volume":"29","author":"Qi","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2019.121809_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2014.03.019","article-title":"Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices","author":"Ottria","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 958"},{"key":"10.1016\/j.jchromb.2019.121809_b0090","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/ac403352e","article-title":"Development and validation of a sensitive UPLC-ESI-MS\/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids","volume":"86","author":"Gouveia-Figueira","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2018.06.016","article-title":"Recent advances in LC-MS \/ MS methods to determine endocannabinoids in biological samples: application in neurodegenerative diseases","author":"Marchioni","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2019.121809_b0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpha.2013.11.004","article-title":"Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy","volume":"4","author":"Liput","year":"2014","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2019.121809_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2014.11.001","article-title":"A quantitiative LC-MS\/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma","volume":"976\u2013977","author":"Gachet","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2019.121809_b0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ejlt.201500115","article-title":"Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS\/MS","volume":"118","author":"Garst","year":"2016","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.jchromb.2019.121809_b0115","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00216-014-8384-5","article-title":"A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells","volume":"407","author":"Ivanov","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0120","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1007\/s00216-015-8559-8","article-title":"Quantitative profiling of endocannabinoids in lipoproteins by LC-MS\/MS","volume":"407","author":"Bilgin","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/dta.1561","article-title":"Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans","volume":"6","author":"Thieme","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2019.121809_b0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.plefa.2017.06.004","article-title":"Levels of oxylipins, endocannabinoids and related lipids in plasma before and after low-level exposure to acrolein in healthy individuals and individuals with chemical intolerance","volume":"121","author":"Claeson","year":"2017","journal-title":"Prostagland. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.jchromb.2019.121809_b0135","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00216-017-0300-3","article-title":"A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples","volume":"409","author":"Marchioni","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.aca.2018.08.062","article-title":"Polymeric ionic liquid open tubular capillary column for on-line in-tube SPME coupled with UHPLC-MS\/MS to determine endocannabinoids in plasma samples","volume":"1045","author":"Souza","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2019.121809_b0145","article-title":"Current advances and applications of in-tube solid-phase microextraction","volume":"111","author":"Donizeti","year":"2019","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2019.121809_b0150","article-title":"Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by LC-MS\/MS","author":"Luis","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2019.121809_b0155","first-page":"257","article-title":"Development of molecularly imprinted polymers for solid phase extraction of parabens in plasma samples and analysis by UHPLC-MS\/MS","volume":"28","author":"Rold\u00e3o","year":"2017","journal-title":"J. Brazil. Chem. Soc."},{"key":"10.1016\/j.jchromb.2019.121809_b0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chroma.2013.07.030","article-title":"Ultrasound-assisted extraction followed by disposable pipette purification for the determination of polychlorinated biphenyls in small-size biological tissue samples","volume":"1317","author":"Pena-Abaurrea","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2019.121809_b0165","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, M10 Bioanalytical Method Validation, 2018. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry (accessed July 24, 2019)."},{"key":"10.1016\/j.jchromb.2019.121809_b0170","unstructured":"European Medicines Agency, International Council for Hamonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Guideline M10 on Bioanalytical Method Validation 44 (2019). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-ich-guideline-m10-bioanalytical-method-validation-step-2b_en.pdf (accessed July 24, 2019)."},{"key":"10.1016\/j.jchromb.2019.121809_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2008.08.040","article-title":"A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices","volume":"384","author":"Marczylo","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2019.121809_b0180","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jchromb.2009.04.010","article-title":"Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"Balvers","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2019.121809_b0185","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.jchromb.2010.09.024","article-title":"Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry","volume":"878","author":"Amoako","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2019.121809_b0190","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbalip.2011.08.004","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective","volume":"1811","author":"Zoerner","year":"2011","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jchromb.2019.121809_b0195","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/brain\/awm160","article-title":"The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis","volume":"130","author":"Centonze","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jchromb.2019.121809_b0200","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/jnnp.2007.139071","article-title":"Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis","volume":"79","author":"Di Filippo","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jchromb.2019.121809_b0205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1528-1167.2009.02334.x","article-title":"Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy","volume":"51","author":"Romigi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchromb.2019.121809_b0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jchromb.2019.121809_b0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/abio.2000.4509","article-title":"Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry","volume":"280","author":"Giuffrida","year":"2000","journal-title":"Anal. Biochem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219306877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219306877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:58:30Z","timestamp":1761605910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023219306877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"alternative-id":["S1570023219306877"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.121809","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of anandamide in cerebrospinal fluid samples by disposable pipette extraction and ultra-high performance liquid chromatography tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.121809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121809"}}